Parison Amy

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -25% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Parison Amy's trades of Editas Medicine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
344.29
Quantity 95,807 +42.1%
Value US$1,304,544
Transaction date
Sale
Price
317.23
Quantity 85,012 +48.6%
Value US$4,477,514
Transaction date
Sale
Price
149.62
Quantity 46,893 +46.9%
Value US$3,878,826
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-03
S Sale
95,807 +42.1%
344.29
US$1,304,544 		95,807 +42.1% 344.29 US$1,304,544
2026-08-05 2026-08-03
S Sale
85,012 +48.6%
317.23
US$4,477,514 		85,012 +48.6% 317.23 US$4,477,514
2026-06-05 2026-06-03
S Sale
46,893 +46.9%
149.62
US$3,878,826 		46,893 +46.9% 149.62 US$3,878,826
2026-03-04 2026-03-03
S Sale
474 -3.0%
2.02
US$957 		474 -3.0% 2.02 US$957
2025-12-04 2025-12-03
S Sale
461 -2.8%
2.15
US$993 		461 -2.8% 2.15 US$993
2025-09-04 2025-09-03
S Sale
458 -2.7%
2.60
US$1,189 		458 -2.7% 2.60 US$1,189
2025-08-08 2025-08-07
S Sale
679 -3.9%
2.58
US$1,752 		679 -3.9% 2.58 US$1,752
2025-06-04 2025-06-03
S Sale
446 -2.5%
1.72
US$769 		446 -2.5% 1.72 US$769